Intrinsic Value of S&P & Nasdaq Contact Us

Omnicell, Inc. OMCL NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
46/100
0/7 Pass
SharesGrow Intrinsic Value
$781.68
+2051.6%
Analyst Price Target
$55.25
+52.1%

Stock Statistics — OMCL

Omnicell, Inc. (OMCL) has a market capitalization of $1.65B and trades at $36.33. The 52-week range is 22.66-55.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 814.6, Earnings Per Share (EPS) of $0.04, annual revenue of $1.18B.

The stock has a beta of 0.86, operates in the Healthcare sector.

Trading Data
Current Price$36.33
52-Week Range22.66-55
Volume415.76K
Avg Volume (30D)637.3K
Market Cap$1.65B
Beta (1Y)0.86
Company
IPO Date2001-08-09
Employees3,620
CEORandall A. Lipps
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS68213N1090
CUSIP68213N109
Income (Latest Year)
Revenue$1.18B
Gross Profit$503.44M
EBITDA$96.29M
Operating Income$5.16M
Net Income$2.05M
EPS$0.04
EPS Diluted$0.04
Shares Outstanding$45.97M
Balance Sheet (Latest Year)
Total Assets$1.97B
Current Assets$680.07M
Cash & ST Investments$196.52M
Total Liabilities$742.91M
Total Debt$204.35M
Net Debt$7.83M
Total Equity$1.23B
Debt / Equity0.17
Valuation Ratios
P/E Ratio814.6
P/S Ratio1.39
P/B Ratio1.34
EV/EBITDA (approx)17.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message